2021 April 20 - Bio-Techne Genomics Global Oncology Summit - North American Region
Asmerom Sengal, MD, Ph.D.,
Translational Research Institute (TRI), Australia
Nallasivam Palanisamy, Ph.D.
Department of Urology, Henry Ford Health System, USA
Lasse Sommer Kristensen, Ph.D.,
Associate Professor, Department of Biomedicine,
Aarhus University, Denmark
Anushka Dikshit, Ph.D.,
Advanced Cell Diagnostics, a Bio-Techne Brand
at ABRF 2021 - Innovation Theater
The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights into tumor immunology, the complex and heterogeneous tumor microenvironment and its dynamics in cancer initiation, progression, and metastasis. Using the different assays under the RNAscope technology umbrella, it is possible to simultaneously visualize and assess the gene expression of cytokines, chemokines, immune cell markers, tumor cell markers and checkpoint markers within the tumor microenvironment (TME).
- Learn how experts in the field of Oncology have utilized the RNAscope, BaseScope™ and Co-Detection Workflow Assays to address pertinent questions in their research.